These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3522217)

  • 1. Early cellular events in pulmonary fibrosis.
    Reiser KM; Last JA
    Exp Lung Res; 1986; 10(4):331-55. PubMed ID: 3522217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of pulmonary fibrosis and current treatment.
    Kuwano K; Hagimoto N; Hara N
    Curr Mol Med; 2001 Nov; 1(5):551-73. PubMed ID: 11899231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolar macrophage stimulation of lung fibroblast growth in asbestos-induced pulmonary fibrosis.
    Lemaire I; Beaudoin H; Massé S; Grondin C
    Am J Pathol; 1986 Feb; 122(2):205-11. PubMed ID: 3946556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters.
    Chandler DB; Hyde DM; Giri SN
    Am J Pathol; 1983 Aug; 112(2):170-7. PubMed ID: 6192723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of human amniotic epithelial cells in mouse models of bleomycin-induced lung fibrosis: A systematic review and meta-analysis.
    He F; Zhou A; Feng S
    PLoS One; 2018; 13(5):e0197658. PubMed ID: 29772024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis. Comparison with other interstitial lung diseases.
    Haslam PL; Dewar A; Butchers P; Primett ZS; Newman-Taylor A; Turner-Warwick M
    Am Rev Respir Dis; 1987 Jan; 135(1):35-47. PubMed ID: 2432812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis.
    Huaux F; Liu T; McGarry B; Ullenbruch M; Xing Z; Phan SH
    J Immunol; 2003 Nov; 171(10):5470-81. PubMed ID: 14607953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial pulmonary fibrosis--which cell is the culprit?
    Snider GL
    Am Rev Respir Dis; 1983 May; 127(5):535-9. PubMed ID: 6189433
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathogenesis of idiopathic pulmonary fibrosis].
    Buhl R; Meier-Sydow J; Vogelmeier C
    Immun Infekt; 1995 Jun; 23(3):92-6. PubMed ID: 7615308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J; Klar B; Hardung-Backes M
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional analysis of the 120-ml bronchoalveolar lavage. Determination of the best specimen for diagnosis of sarcoidosis.
    Winterbauer RH; Wu R; Springmeyer SC
    Chest; 1993 Aug; 104(2):344-51. PubMed ID: 8339617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic interstitial pneumonias: Primum movens: epithelial, endothelial or whatever.
    Calabrese F; Giacometti C; Rea F; Loy M; Valente M
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S15-23. PubMed ID: 16457013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function.
    Wallaert B; Hatron PY; Grosbois JM; Tonnel AB; Devulder B; Voisin C
    Am Rev Respir Dis; 1986 Apr; 133(4):574-80. PubMed ID: 3963625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary fibrosis in a patient treated with bumetanide: clinical improvement associated with transition from a granulocytic to lymphocytic alveolitis.
    Barnett R; Israel HL; Scott R; Fish JE; Peters SP
    Respir Med; 1990 Jan; 84(1):71-5. PubMed ID: 2371426
    [No Abstract]   [Full Text] [Related]  

  • 15. Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast proliferation and collagen production.
    Clark JG; Kostal KM; Marino BA
    J Clin Invest; 1983 Dec; 72(6):2082-91. PubMed ID: 6196378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytokines and pulmonary fibroses].
    Carré P; Léophonte P
    Rev Mal Respir; 1993; 10(3):193-207. PubMed ID: 7688479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis of idiopathic interstitial pneumonia/idiopathic pulmonary fibrosis: cellular and molecular biology of the disease].
    Yoshimura K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():20-31. PubMed ID: 8007466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Latent alveolitis in systemic disease. The transition between the normal and the pathological].
    Wallaert B; Dugas M; Tonnel AB; Voisin C
    Rev Mal Respir; 1990; 7(1):17-25. PubMed ID: 2251429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic suppression of the neutrophil component of the alveolitis in idiopathic pulmonary fibrosis.
    O'Donnell K; Keogh B; Cantin A; Crystal RG
    Am Rev Respir Dis; 1987 Aug; 136(2):288-92. PubMed ID: 3619187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of TGF-beta in pulmonary fibrosis.
    Khalil N; Greenberg AH
    Ciba Found Symp; 1991; 157():194-207; discussion 207-11. PubMed ID: 1712697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.